Virtus Investment Advisers, Inc. Xeris Biopharma Holdings, Inc. Transaction History
Virtus Investment Advisers, Inc.
- $286 Million
- Q2 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 21,274 shares of XERS stock, worth $196,571. This represents 0.03% of its overall portfolio holdings.
Number of Shares
21,274
Previous 48,288
55.94%
Holding current value
$196,571
Previous $265,000
62.64%
% of portfolio
0.03%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding XERS
# of Institutions
208Shares Held
89.9MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$95.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$90.7 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$35.4 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$35 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$33.7 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.26B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...